These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37000176)

  • 1. A Symbolic Regression Model for the Prediction of Drug Binding to Human Liver Microsomes.
    Van Rompaey D; Morrison D; Van Den Bergh A; Wegner JK
    Mol Pharm; 2023 May; 20(5):2436-2442. PubMed ID: 37000176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of Fraction Unbound in Microsomal and Hepatocyte Incubations: A Comparison of Methods across Industry Datasets.
    Winiwarter S; Chang G; Desai P; Menzel K; Faller B; Arimoto R; Keefer C; Broccatell F
    Mol Pharm; 2019 Sep; 16(9):4077-4085. PubMed ID: 31348668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-specific binding of compounds in
    Gardner I; Xu M; Han C; Wang Y; Jiao X; Jamei M; Khalidi H; Kilford P; Neuhoff S; Southall R; Turner DB; Musther H; Jones B; Taylor S
    Xenobiotica; 2022 Aug; 52(8):943-956. PubMed ID: 36222269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct determination of the ratio of unbound fraction in plasma to unbound fraction in microsomal system (fu p/fu mic) for refined prediction of phase I mediated metabolic hepatic clearance.
    Deshmukh SV; Harsch A
    J Pharmacol Toxicol Methods; 2011; 63(1):35-9. PubMed ID: 20433934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct Comparison of Total Clearance Prediction: Computational Machine Learning Model versus Bottom-Up Approach Using In Vitro Assay.
    Kosugi Y; Hosea N
    Mol Pharm; 2020 Jul; 17(7):2299-2309. PubMed ID: 32478525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Fragment-Based Approach for the Computational Prediction of the Nonspecific Binding of Drugs to Hepatic Microsomes.
    Nair PC; McKinnon RA; Miners JO
    Drug Metab Dispos; 2016 Nov; 44(11):1794-1798. PubMed ID: 27543205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties.
    Austin RP; Barton P; Cockroft SL; Wenlock MC; Riley RJ
    Drug Metab Dispos; 2002 Dec; 30(12):1497-503. PubMed ID: 12433825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsome composition-based model as a mechanistic tool to predict nonspecific binding of drugs in liver microsomes.
    Poulin P; Haddad S
    J Pharm Sci; 2011 Oct; 100(10):4501-17. PubMed ID: 21574165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A probabilistic method to report predictions from a human liver microsomes stability QSAR model: a practical tool for drug discovery.
    Aliagas I; Gobbi A; Heffron T; Lee ML; Ortwine DF; Zak M; Khojasteh SC
    J Comput Aided Mol Des; 2015 Apr; 29(4):327-38. PubMed ID: 25708388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular binding of drugs: correction for unbound fraction in hepatocyte incubations using microsomal binding or drug lipophilicity data.
    Kilford PJ; Gertz M; Houston JB; Galetin A
    Drug Metab Dispos; 2008 Jul; 36(7):1194-7. PubMed ID: 18411401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of human pharmacokinetics--improving microsome-based predictions of hepatic metabolic clearance.
    Fagerholm U
    J Pharm Pharmacol; 2007 Oct; 59(10):1427-31. PubMed ID: 17910819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of in silico models for human liver microsomal stability.
    Lee PH; Cucurull-Sanchez L; Lu J; Du YJ
    J Comput Aided Mol Des; 2007 Dec; 21(12):665-73. PubMed ID: 17599241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of intrinsic clearance for prediction of human hepatic clearance.
    Chao P; Uss AS; Cheng KC
    Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):189-98. PubMed ID: 20073997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based prediction of the nonspecific binding of drugs to hepatic microsomes.
    Li H; Sun J; Sui X; Yan Z; Sun Y; Liu X; Wang Y; He Z
    AAPS J; 2009 Jun; 11(2):364-70. PubMed ID: 19440845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of in silico models for fraction of unbound drug in human liver microsomes.
    Gao H; Steyn SJ; Chang G; Lin J
    Expert Opin Drug Metab Toxicol; 2010 May; 6(5):533-42. PubMed ID: 20233033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro analysis of human drug glucuronidation and prediction of in vivo metabolic clearance.
    Soars MG; Burchell B; Riley RJ
    J Pharmacol Exp Ther; 2002 Apr; 301(1):382-90. PubMed ID: 11907196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting Mouse Liver Microsomal Stability with "Pruned" Machine Learning Models and Public Data.
    Perryman AL; Stratton TP; Ekins S; Freundlich JS
    Pharm Res; 2016 Feb; 33(2):433-49. PubMed ID: 26415647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prediction of human clearance from hepatic microsomal metabolism data.
    Obach RS
    Curr Opin Drug Discov Devel; 2001 Jan; 4(1):36-44. PubMed ID: 11727321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative assessment of empirical and physiological approaches on predicting human clearances.
    Tamaki S; Komura H; Kogayu M; Yamada S
    J Pharm Sci; 2011 Mar; 100(3):1147-55. PubMed ID: 20830811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Silico Prediction of Human and Rat Liver Microsomal Stability via Machine Learning Methods.
    Li L; Lu Z; Liu G; Tang Y; Li W
    Chem Res Toxicol; 2022 Sep; 35(9):1614-1624. PubMed ID: 36053050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.